Peggy Lipp
Director, Regulatory Affairs, Business Intelligenc
Pharmaceuticals
Debiopharm
Switzerland
Biography
Mrs Lipp received her M.Sc. (Dipl. Ing.) degree in Biotechonology from Technical university of Graz in Austria and is experienced in leading the development of global regulatory strategies in a broad number of therapeutic areas for both early and late stage products. Before joining Debiopharm, Ms. Lipp was Director of Regulatory Affairs in Janssen, where she was directly responsible for successful key product approvals across multiple therapeutic areas. Prior to joining Janssen, she held multiple regulatory and research positions with increasing responsibilities in Biogen, Baxter, ApoPharma, and Mount Sinai School of Medicine. She joined Debiopharm in 2015 to lead Regulatory Affairs, Market Access and Business Intelligence teams.
Research Interest
Biotechonology
